Manufacturing live biotherapeutic product is both
technically challenging and financially demanding; as a result, innovator firms
are becoming increasingly reliant on contract service providers to access specialized
facilities and optimize overall costs.
Roots Analysis is pleased to announce
the publication of its recent study, titled, “Live Biotherapeutic Products and
Microbiome Contract Manufacturing
Market, 2020-2030: Focus on Active Pharmaceutical Ingredients and Finished
Dosage Forms, 2020-2030.”
The report features an extensive study of the current
landscape and future opportunities related to contract services for microbiome
therapeutics. The study features an in-depth analysis, highlighting the
capabilities of a diverse set of contract service providers, including CMOs and
CDMOs. Amongst other elements, the report includes:
§ A
detailed review of the overall landscape of companies offering contract
services for manufacturing of microbiome therapeutics.
§ A
list of companies with in-house manufacturing facilities for microbiome
therapeutics.
§ Elaborate
profiles of key industry players (large and mid-sized companies, established
before 2000) based in North America, Europe and Asia-Pacific.
§ An
assessment of microbiome contract manufacturing capability in different
regions.
§ A
list of nearly 50 microbiome-focused drug developers that are anticipated to
partner with contract manufacturers.
§ A
detailed clinical trial analysis of more than 150 completed, ongoing and
planned studies of various microbiome therapeutics sponsored by both industry
and non-industry players.
§ An
estimate of the overall, installed capacity for manufacturing of microbiome
therapeutics, taking into consideration the capabilities of various stakeholders.
§ An
informed estimate of the annual clinical demand for microbiome therapeutics,
taking into account the target patient population in ongoing and planned
clinical trials of microbiome therapeutics, sponsored by both industry and
non-industry players.
§ A
qualitative analysis, highlighting the various factors that need to be taken
into consideration by microbiome therapeutics developers while deciding whether
to manufacture their respective products in-house or engage the services of a
CMO.
§ A
review of the varied microbiome-focused initiatives of big pharma players.
A detailed market forecast, featuring analysis
of the current and projected future opportunity across key market segments
(listed below):
§ Type
of Product Manufactured
§ Active
Pharmaceutical Ingredients (APIs)
§ Finish
Drug Formulations (FDFs)
§ Type
of Type of Formulation
§ Solid
Formulations
§ Oral
Liquids
§ Injectables
§ Others
§ Scale
of Operation
§ Clinical
§ Commercial
§ Company
Size
§ Small-sized
§ Mid-sized
§ Large
§ Key
Geographical Regions
§ North
America
§ Europe
§ Asia-Pacific
and Rest of the World
Key
companies covered in the report
§ Biose®
§ BJP
Laboratories
§ Capsugel
(acquired by Lonza)
§ Cerbios-Pharma
§ Cobra
Biologics (acquired Cognate Bioservices)
§ Inpac
Probiotics
§
Paragon Bioservices (a unit of Catalent Biologics)
§ UAS
Labs
For
more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html
Other Recent Offerings
1.
HPAPI and Cytotoxic Drugs Manufacturing Market (3rd Edition), 2020-2030
2.
Antibody Contract Manufacturing Market, 2020 – 2030
3.
The Human Microbiome
Market: Focus on Therapeutics (including gut-brain axis targeting drugs),
Diagnostics and Fecal Microbiota Therapies (3rd Edition), 2019-2030
About Roots Analysis
Roots
Analysis is one of the fastest growing market research companies, sharing fresh
and independent perspectives in the bio-pharmaceutical industry. The in-depth
research, analysis and insights are driven by an experienced leadership team
which has gained many years of significant experience in this sector. If you’d
like help with your growing business needs, get in touch at
info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav
Chaudhary
+1
(415) 800 3415
gaurav.chaudhary@rootsanalysis.com
